D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial

Overview of attention for article published in Orphanet Journal of Rare Diseases, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 X post from an account with 8,293 followers.

#PMM2CDG is the most prevalent of the #CongenitalDisordersOfGlycosylation with only symptomatic therapy. Read about an open-label pilot trial with D-#galactose as supportive treatment in @ojrarediseases w/@rarediseasesnet's @FrontierCDG: https://t.co/YphZc

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.